Infertility is the major problem worldwide and results in the abnormal functioning of the male or female reproductive system and can manifest as an inability to get pregnant, inability to maintain the pregnancy or inability to maintain the pregnancy to a live birth. The main objective of fertilization is to increase the number of sperms that reach the fallopian tubes, so that the chances of pregnancy increases. Intrauterine insemination (IUI) is a type of fertility treatment that aims to increase the number of sperms inside the woman’s uterus to increase the rate of fertilization.
The Intrauterine Insemination (IUI) is minimally invasive technique and less expensive option compared to other fertility treatment options. According to Centers for Disease Control and Prevention, data for 2011- 2013 in U.S reported that about 7.5 million women had decreased the ability to get pregnant or carry a baby to long term.
Infertility can be due to both men and women or due to some unknown problems. Growing number of patients suffering from problems related to ovulation, uterine problems, blocked fallopian tube, poor diet, age, and others. Higher consumption of alcohol, drug abuse, smoking, chemotherapy, radiation therapy, strong medication are some of the risk factors causing fertility problem among men.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6600
The reasons for Intrauterine Insemination (IUI) includes, unknown infertility problems, cervical mucus problems, ejaculation dysfunction and others. Nowadays, the trend of delayed marriage is rising, and women are waiting until their mid-30s and 40s to have kids.
This has led to decreasing women’s fertility in later stage of life. Increased age results to reduced ovulation and miscarriage chances and other health problems after. Many diagnostic tests are done by doctors to find the cause of infertility; this test includes ultrasound, sperm and ovum studies, ovulation tests, laparoscopy and others
Effectiveness of IUI Procedure
The technological advancement in the Intrauterine Insemination (IUI) procedure has increase the chances to conceive. The success of IUI procedure depends on several factors such as age, cause of infertility, medication used and others. Fertility drugs and IUI procedure are the initial steps that are used to address infertility problems as it does not control the/involve the use of woman’s eggs.
For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-6600
The success rate of IUI procedure with some fertility medication increases up to 8% to 20% per cycle. IVF using a woman’s own eggs; the average success rate is recorded to be 40% to 45% for patients under age 35. IUI is the first line of treatment for the patients suffering from infertility and this treatment is very effective during, cervical issues, mild ovulation issues, mild male-factor infertility and others.
Increased incidence of infertility among both men and women, various global initiatives for sexual and reproductive health, increased prevalence of diseases such as polycystic ovary syndrome; uterine fibroids, endometriosis and others leads to infertility due to high dose drugs that damage ovum/sperm. Due to these reasons the market for global Intrauterine Insemination (IUI) Treatment is anticipated to grow during the forecast period.
Factor Driving Intrauterine Insemination (IUI) Treatments Market
Researchers are focusing on health problems related to women and men due to the increased rate of infertility. Several medicines are used to treat infertility problems or enhance fertility among women. Based on the test results the treatment is prescribed, technological advancement in devices with improved sensitivity, increasing first-time pregnancy age, rising out-of-pocket healthcare expenditure are some of the factors driving the Intrauterine Insemination (IUI) Treatment market.
Changing lifestyles had led increased number of cases of gynaecological disorders such as fibroids, uterine polyps, polycystic ovarian disease, endometriosis, and unexplained infertility that lead to difficulties in conceiving. This scenario is expected to result in increased use of fertility treatment options to maximize chances of conception and boost the Intrauterine Insemination (IUI) Treatments Market
Safety of IUI Procedure
The IUI procedure is safe, but sometimes multiple pregnancy occurs that can cause serious health condition to both mother and baby. The babies born may be pre-mature with low birth weight. The IUI procedure is less expensive than other assisted reproductive technology (ART) treatments. The better results are shown through IUI procedure than the use of any other fertility drugs. This fertility procedure allows fertilization in the natural way.
Regional Market Outlook
On the basis of regional presence, global Intrauterine Insemination (IUI) treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America leads the Intrauterine Insemination market reasons being lifestyle changes, new product innovations, and early treatment adoption. Europe is the second leading market for Intrauterine Insemination treatment market due to development activities and large research base.
The Asia Pacific market is also expected to grow at a higher rate owing to changing lifestyle, large target patient pool, rapid population growth, adoption of western lifestyle, and growth in research and development. These factors are likely to drive the market growth of Intrauterine Insemination market during the forecast period globally.
Competition Outlook
Some of the players identified in the global Intrauterine Insemination (IUI) market are Labotect GmbH, Fernandez Hospital, Apollo Fertility, Sunflower Hospital, Brigham and Women’s Hospital, BMI Healthcare, University Hospitals Coventry and Warwickshire, Conceive Hospital, London Women’s Clinics, Site Map Privacy Policy Terms & Conditions Accessibility Contact Us Guy’s and St Thomas’ Private Healthcare and Others.
The hospitals will provide full Procedure of IUI with proper care and medications. The synergies between the companies is presenting immediate growth impact rather than acquisitions and mergers. However, increase in infertility cases, rise in IUI procedure and increases awareness about the IUI with no ethical issues are some of the factors offering global opportunity to its manufacturers to manufacturer high grade Intrauterine Insemination (IUI) fertility treatment.
Key data points covered in report
The report covers exhaustive analysis on:
- Intrauterine Insemination (IUI) Treatment Market by test type, end user and region
- Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by test type, end user and country segments
- Intrauterine Insemination (IUI) Treatment Market Dynamics & Opportunity Assessment
- Historical Actual Market Size, 2013 – 2017
- Intrauterine Insemination (IUI) Treatment Market Size & Forecast 2018-2028
- Intrauterine Insemination (IUI) Treatment Agents Current Trends/Issues/Challenges
- Competition & Companies involved
Research Methodology
The market sizing of Intrauterine Insemination (IUI) Treatment will be done by adoption data triangulation approach. Demand side approach will be followed to assess the actual market size of Intrauterine Insemination (IUI) Treatment. Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies.
Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Market by End user
- Hospitals
- Fertility Clinics
- Gynecologist & Sonography Clinic
- Others
Market by Region
- North America
- Latin America
- Europe
- Asia Pacific Excluding Japan
- Japan
- Middle East & Africa
For Read More Related Insights:
https://faceblox.mn.co/posts/22943731?utm_source=manual
https://drujrake.mn.co/posts/22943735?utm_source=manual
https://cipmo-system.mn.co/posts/22943750?utm_source=manual
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com